| Literature DB >> 29146594 |
András D Tóth1, Susanne Prokop1, Pál Gyombolai1,2, Péter Várnai1,2, András Balla1,2, Vsevolod V Gurevich3, László Hunyady4,2, Gábor Turu1,2.
Abstract
β-Arrestins are key regulators and signal transducers of G protein-coupled receptors (GPCRs). The interaction between receptors and β-arrestins is generally believed to require both receptor activity and phosphorylation by GPCR kinases. In this study, we investigated whether β-arrestins are able to bind second messenger kinase-phosphorylated, but inactive receptors as well. Because heterologous phosphorylation is a common phenomenon among GPCRs, this mode of β-arrestin activation may represent a novel mechanism of signal transduction and receptor cross-talk. Here we demonstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, Gq/11-coupled GPCR, or epidermal growth factor receptor stimulation promotes β-arrestin2 recruitment to unliganded AT1 angiotensin receptor (AT1R). We found that this interaction depends on the stability lock, a structure responsible for the sustained binding between GPCRs and β-arrestins, formed by phosphorylated serine-threonine clusters in the receptor's C terminus and two conserved phosphate-binding lysines in the β-arrestin2 N-domain. Using improved FlAsH-based serine-threonine clusters β-arrestin2 conformational biosensors, we also show that the stability lock not only stabilizes the receptor-β-arrestin interaction, but also governs the structural rearrangements within β-arrestins. Furthermore, we found that β-arrestin2 binds to PKC-phosphorylated AT1R in a distinct active conformation, which triggers MAPK recruitment and receptor internalization. Our results provide new insights into the activation of β-arrestins and reveal their novel role in receptor cross-talk.Entities:
Keywords: G protein-coupled receptor (GPCR); angiotensin II; arrestin; bioluminescence resonance energy transfer (BRET); mitogen-activated protein kinase (MAPK); protein kinase C (PKC); receptor endocytosis
Mesh:
Substances:
Year: 2017 PMID: 29146594 PMCID: PMC5777260 DOI: 10.1074/jbc.M117.813139
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157